LinusBio has launched the Clearstrand-ASD, a pioneering diagnostic test that uses a single strand of hair to help assess autism risk in children aged one to 36 months. While it does not provide an official diagnosis, it can rule out autism in kids at elevated risk. The test analyzes metabolic history through advanced laser and machine-learning technology to measure exposure to potential toxins linked to autism. With an accuracy of 92.5%, this innovation aims to reduce the lengthy average wait for a diagnosis and is currently available in 44 states.
The Clearstrand-ASD test, unique in requiring just a strand of hair, helps physicians rule out autism risk in young children, integrating advanced technology for analysis.
This test analyzes hair using lasers and machine learning to assess a child's metabolic history, highlighting potential toxin exposure linked to autism.
With a reported accuracy of 92.5%, the Clearstrand-ASD test provides rapid results to families, reducing the lengthy wait associated with traditional autism diagnosis methods.
As per CDC data, autism diagnosis averages at age four, yet signs may present much earlier, underscoring the importance of timely assessments for at-risk children.
Collection
[
|
...
]